Sunday, May 26, 2024

1. prof. dr. Rainer Srečko dr. med, Klinični ginekološki pregledi 1971
2. Diedrich K, Felberbaum R, Baumann P. Assistierte Reproduktion – Ein Überblick. Gynäkologe
3. Küpker W. Intrazytoplasmatische Spermatozoeninjektion. TW Gynäkologie
4. Mulayim B, Demirbasoglu S, Oral O. Unicornuate uterus and unilateral ovarian agenesis associated with pelvic kidney.Surg Endosc.
5.Ludwig KS. The Mayer-Rokitansky-Kuster syndrome. An analysis of its morphology and embryology. Part I: Morphology.Arch Gynecol Obstet.
6. Elford KJ, Spence JE. The forgotten female: Pediatric and adolescent gynecological concerns and their reproductive consequences.J Pediatr Adolesc Gynecol. 2002 Apr;
7. Colacurci N, De Franciscis P, Fornaro F, Fortunato N, Perino A. The significance of hysteroscopic treatme
8.Troiano RN. Magnetic resonance imaging of mullerian duct anomalies of the uterus.Top Magn Reson Imaging.
9. Propst AM, Hill JA 3rd. Anatomic factors associated with recurrent pregnancy loss.Semin Reprod Med. 2000
10. Livia Puljak dr. med. Histologija i Embriologija 2009/2010
11. Kraus S. Diabetes und Schwangerschaft. Seminarunterlagen. Deutsche Akademie für Ernährungsmedizin.
12. Briese V, Kerler B. Gestationsdiabetes – Diagnostik unter Berücksichtigung anamnestischer Risikofaktoren.
13. Foth D. Hormonelle Therapie von Blutungsstörungen. Frauenarzt,
14. Kaiser R. Diagnose und Therapie von Zyklusstörungen bei Jugendlichen. Frauenarzt
15. Graf M; Distler W. Pathogenese der gestörten Ovarialfunktion. Gynäkologe
16. Rowland AS et al. Influence of Medical Conditions and Lifestyle Factors on the Menstrual Cycle. Epidemiology
17. prof. dr. Marjan Pajtnar dr. med, dr. živa Antolič – Novak dr. med; Nosečnost in vodenje poroda 2004
18. Tammaa A, Teich G, Scholl T, Salzer H. Ethnologie als Risikofaktor für Gestationsdiabetes in Mitteleuropa. Geb Fra 2001
19. Martius J. – Infektiologishes Screening in der Schwangerschaft
20. Tercanli S., Enders G., Holzgreve W. – Infektionen mit Roteln, Tocoplasmose, Zytomegalie, Varizellen und parvovirus
21. Friese K. – Vorzeitiger Blasensprung und Infektionsaspekte
22. Schmid F. Die Alkoholembriopathie, das klinische Bild. Biologische Medizin 2. Kesmodel U, Wisborg K, Olsen s et al. Moderate Alcohol Intake during Pregnancy and the Risk of Stillbirth and Death in the First Year of Life. Am J
23. Bookstein FL, Sampson PD, Streissguth AP, Connor PD. Geometric morphometrics of corpus callosum and subcortical structures in the fetal alcohol-affected brain. Teratology
24. Ghiatas AA. The spectrum of pelvic inflammatory disease
25. Blake DR. Adolescent Sexually
26. Wachter I. Jugendgynakologie
27. Technical Bulletin #196, Operative Vaginal Delivery (August,1994), ACOG.    The 4th edition of Guidelines for Perinatal Care (1997), American Academy of Pediatrics and ACOG.
28. Paluska SA. Vacuum-assisted vaginal delivery. Am Fam Physician 1997.
29. Bofill, JA., et al. A randomized prospective trial of the obstetric forceps versus the M-cup vacuum extractor. Am J Obstet & Gynecol 1996.
30. Vacca A. Birth by vacuum extraction: neonatal outcome. J Paediatr Child Health, 1996.
31. Chadwick LM, Pemberton PJ, Kurinczuk JJ. Neonatal subgleal haematoma: associated risk factors, complications and outcome. J Paediatr Child Health 1996.
32. Cavlovich Faye E. Subgaleal Hemorrhage in the Neonate. Journal of Obstetric Gynecologic & Neonatal Nursing; Principles & Practice. Volume 24, No.5, February, 1994.
33. Smith, SA., et al. Subgaleal Hematoma: The Need for Increased Awareness of Risk. J Fam Pract. December,1995.
34. Perrin RG, Rutka JT, Drake JM, et al. Management and outcomes of posterior fossa subdural hematomas in neonates. Neurosurgery 1997.
35. Michael S. Loughnan; Adrian Bruce (2003). Anterior Eye Disease and Therapeutics A-Z. Oxford: Butterworth-Heinemann.
36. Radcliffe, Walter. Milestones in midwifery; And, the Secret Instrument Jeremy Norman Co. 1989
37. Edward H. Dennen. Forceps Deliveries. F.A.Davis Co (1955)
38. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first trimester screening of Down’s syndrome. Prenatal Diagnosis 1997;
39. Wenstrom KD, Desai R, Owen J. DuBard MB et al. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in woman >35 years old. Am J Obstet Gynecol 1995;
40. Germer U, Gembruch U, Geipel A, Krapp M, Diedrich. Frühes Fehlbildunsscreening als Entscheidunggrundlage für oder gegen einer Karyotipisierung in der Schwangerschaft. Frauenarzt 1998;
41. “National Autism Treatment Plan for Excellence in IDEA” Petition to the President of the United States. Accessed 23 Sep 2006.
42. “How Common Are Autism Spectrum Disorders (ASD)?” Centers for Disease Control and Prevention. Accessed 23 Sep 2006.
43. “Autism in schools: Crisis or challenge?” The National Autistic Society. Accessed 23 Sep 2006.
44. “International Programme on Chemical Safety. Environmental Health Criteria 22. Ultrasound.” 1982. United Nations Environment Programme, International Labour Organisation and International Radiation Protection Association. Accessed 22 May 2006.
45. Keiler, H., et al. 2001. Sinistrality—a side-effect of prenatal sonography: A comparative study of young men. Epidemiology 12(6): 618–23; Campbell, J.D., et al. 1993. Case-controlled study of prenatal ultrasonography exposure in children with delayed speech. Can Med Assoc J 149: 10, 1435–40.
46. “Ultrasound Can Affect Brain Development.” Truth Out Issues. Accessed 25 Sep 2006.
47. Ang, E.S., Jr., et al. 2006. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. PNAS 103(34): 12903–10. Accessed 11 Aug 2006.
48. Rados, Carol. 2004. FDA Cautions Against Ultrasound “Keepsake” Images. FDA Consumer Magazine. Accessed 11 Sep 2005.
49. Samuel, Eugenie. 2001. Fetuses can hear ultrasound examinations. New Scientist. Accessed 11 May 2006.
50. Miller, M.W., et al. 2002. Hyperthermic teratogenicity, thermal dose and diagnostic ultrasound during pregnancy: implications of new standards on tissue heating. Int J Hyperthermia 18(5): 361–84.
51. Graham, Jr., M., M.J. Edwards and M.J. Edwards. 1998. Teratogen Update: Gestational Effects of Maternal Hyperthermia Due to Febrile Illnesses and Resultant Patterns of Defects in Humans. Teratology 58: 209–21.
52. Clancy, B., R.B. Darlington and B.L. Finlay. 2001. Translating developmental time across mammalian species. Neuroscience 105(1): 7–17.
53. Wilson, D.E. 2004. “Body Function Dependent On Body Temperature.” In Wilson’s Temperature Syndrome—A Reversible Low Temperature Problem. eBook. Accessed 19 Sep 2006.
54. “How enzymes work.” Biotopics
55. Oehninger S. Strategies for the infertile man. Sem Reproductive Med
56. Oliva A, Spira A, Multigner L. Contribution of enviromental factors to the risk of male infertility. Human Reprod
57. Moline JM, Golden AL et al. Exposure to hazardous substances and male reproductive health: a research framework. Environ Health Perspect
58. “The ultrasound procedure: Physical effects and research.” Birth. Accessed 23 Sept 2006.
59. Barnett, S.B. “Can diagnostic ultrasound heat tissue and cause biological effects?” In S.B. Barnett and G. Kossoff, eds. 1998. Safety of Diagnostic Ultrasound. Carnforth, UK: Parthenon Publishing.
60. Edwards, M.J. 1998. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links? Cell Stress Chaperones 3(4): 213–20.
61. Klauck, S.M., et al. 2006. Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry. advance online publication 29 August 2006. doi:10.1038/
62. Betancur, C., M. Leboyer and C. Gillberg. 2002. Increased Rate of Twins among Affected Sibling Pairs with Autism. Am J Hum Genet 70: 1381–83.
63. “Diagnostic Ultrasound Imaging in Pregnancy.” National Institutes of Health Consensus Statement Online.
64. Edwards, M.J., R.D. Saunders and K. Shiota. 2003. Effects of heat on embryos and foetuses. Int J Hyperthermia
65. Milunsky, A., et al. 1992. Maternal heat exposure and neural tube defects. JAMA
66. “Thimerosal in Vaccines.” U.S. Food and Drug Administration. Accessed 21 Sep 2006.
67. “Thimerosal and Vaccines.” Centers for Disease Control. Accessed 27 Sep 2006.
68.”Facts and Statistics.” Autism Society of America. Accessed 21 Sep 2006.
69. Honda, H., Y. Shimizu and M. Rutter. 2005. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 46(6)
70. Taylor, B, et al. 1999. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353(9169)
71. Dales, L., S.J. Hammer and N.J. Smith. 2001. Time Trends in Autism and in MMR Immunization Coverage in California. JAMA 285(22)
72. Stephens, M.B. 2000. American Family Physician Conference Highlights: Majority of Pregnant Women Want Prenatal Ultrasound. Am Fam Physician
73. Wagner, M., and M.G. Wagner. 1994. Pursuing the Birth Machine, 1st ed. French’s Forest, Australia: James Bennett Pty Ltd.
74. Bricker, L., and J.P. Neilson. 2006. “Routine Doppler ultrasound in pregnancy.” The Cochrane Collaboration 3
75. Kleinstein J. Neue Konzepte der Sterilitätsbehandlung in der täglichen Praxis. Klinik für Reproduktionsmedizin und gynäkologische Endokrinologie, Otto von Guericke Universität Magdeburg,
76. Graf M, Distler W. Pathogenese der gestörten Ovarialfunktion. Gynäkoloe  
77. Ricih-Edwards JW, Spiegelman D et al. Physical Activity, Body Mass Index and Ovulatory Disorder Infertility. Epidemiol  
78. Schleußner E, Distler W. Die Therapie der Anovulation mit Antioestrogenen, Prolaktininhibitoren, Kortikosteroiden und Schilddrüsenhormonen. Gyn¨kologe
79. Runnebaum B. Rabe T. Gynäkologische Fortpflanzungsmedizin. Springer Verlag Berlin Heidelberg New York
80. Ludwig M, Diedrich K. Moderne
81.Schweppe KW. Endometriose. Diagnose und Klassifikation. TW Gynäkologie
82. Prentice A. Endometriosis. Regular review.
83. Valle RF. Endometriosis: current concepts and therapy. Int J Gynecol Obstet
84. Smith, M. 2006. “Ultrasound Affects Development of Murine Brains.” Medpage Today. Accessed 13 Aug 2006.
85. “Genital and Urinary Tract Defects.” March of Dimes. Accessed 27 Aug 2006.
86. “Healthy from the Start.” 1999. The Pew Charitable Trusts (Environmental Health Commission). Accessed 25 Sep 2006.
87. Behrman, R.E., and A.B. Stith, eds. 2006. Preterm Birth: Causes, Consequences, and Prevention. Washington, D.C.: National Academies Press. Accessed 20 Sep 2006.
88. “New research offers clues to prevent brain damage in premature babies.” 2006. Medical News Today. Accessed 25 Sep 2006.
89. Ewigman, B.G., et al. 1993. Effect of Prenatal Ultrasound Screening on Perinatal Outcome.
90. Wenstrom KD, Desai R, Owen J. DuBard MB et al. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in woman >35 years old. Am J Obstet Gynecol
91. Germer U, Gembruch U, Geipel A, Krapp M, Diedrich. Frühes Fehlbildunsscreening als Entscheidungsgrundlage für oder gegen einer Karyotipisierung in der Schwangerschaft. Frauenarzt
92. Chitty LS, Pandya P. Ultrasound screening for fetal abnormalities in the first trimester. Prenatal Diagnosis
94. Diseases and conditions: Cystic fibrosis: 
95. Underwood JCE: General and systematic pathology, 4th ed. Edinburgh, Churchill Livingstone, 2004.
96. Kumar V, Cotran RS, Robbins SL: Basic pathology, 7th ed. Philadelphia, Saunders, 2003.

97. E.b. Philip N. Baker Obstetrics by ten teachers, 18th edition, 2006 Edward Arnold publishers ltd.

98. Barry O’Reilly, Cecilia Bottomoley, Janice Rymer; Obstetrics and Gynaecology; 2005 Elsevier Limited

99. Richard L. Drake, A. Wayne Vogl, Adam W. M. Mitchell; Gray’s Anatomy for Students, 2nd edition 2009

100. Lindberg CE. Emergency Contraception for prevention adolescent pregnancy; MCN 2003

101.  Nguyen L, Bianchi – Demicheli F, Ludicke F, Women’s knowledge and opinions of emergency contraception 2003

102. Pollack JS, Daley AM, Improve adolescents access to emergency contraception 2003

103. Raine T. Emergency contarception 2003

104. Fegeler K. Haarausfall bei Frauen, Frauenarzt 1997; 7:1132-1137.
105. Rabe T, Grunwald K, Runnebaum B. Androgenisierung. Diagnostik und Therapie in der Praxis.Diesbach Verlag Berlin, 1992.
106. Runnebaum B, Rabe T. Gynäkologische Endokrinologie. Springer Verlag Berlin Heidelberg New York 1994.

107. Benedetto C. Eicosanoids in Primary Dysmenorrhea, Endometriosis and Menstrual Migraines.

108. Abraham GE. Nutritional Factors in the Etiology of the Premenstrual Tension Syndrom. J Reprod Med

109. Harel Z. Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with Omega-3-Fatty Acids in the Management of Dysmenorrhea in Adolescents.

110. Oyelese, Y. & Ananth, C.V. (2006). Placental abruption. Obstetrics and Gynecology, 108 (4), 1005-1016.
111. Ananth, C.V., Getahun, D., Peltier, M.R. & Smulian, J.C. (2006). Placental abruption in term and preterm gestations. Obstetrics and Gynecology, 107 (4), 785-792.
112. Kay, H.H. (2008). Placenta previa and abruption. In Gibbs, R.S., Karlan, B.Y., Haney, A.R. & Nygaard, I.E. (Eds.): Danforth’s Obstetrics and Gynecology (9th ed., pp.385-399). Philadelphia: Lippincott Williams & Wilkins.
113. Gaufberg, S.V. (2008). Abruptio placentae. Emedicine.
114. Deutsch, A.B., Lynch, O., Alio, A., Salihu, H.M. & Spellacy, W.N. (2010). Increased risk of placental abruption in underweight women. American Journal of Perinatology, 27 (3), 235-240.
115. Oyelese, Y. & Smulian, J.C. Placenta previa, placenta accreta, and vasa previa. (2006). Obstetrics and Gynecology, 107 (4), 927-941.
116. Joy, S., Lyon, D. & Stone, R.A. (2010). Placenta previa. Emedicine.
117. American College of Obstetricians and Gynecologists (ACOG). (2007). ACOG committee opinion number 394: Cesarean delivery on maternal request. Washington, DC: Author.
118. Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., et al. (2010). Maternal outcome after conservative treatment of placenta accreta. Obstetrics and Gynecology, 115 (3), 526-534.
119. Warshak, C.R., Ramos, G.A., Eskander, R., Benirschke, K., Saenz, C.C., et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstetrics and Gynecology, 115 (1), 65-69.
120. Eller, A.G., Porter, T.F., Soisson, P. & Silver, R.,M. (2009). Optimal management strategies for placenta accreta. British Journal of Obstetrics and Gynecology, 116, 648-654.


1. Salk Institute for Biological Studies
2. Johns Hopkins University
3. European Society of Human Reproduction and Embryology (ESHERE)

4. Royal College of Obstetrics and Gynaecology (RCOG)
5. American College of Obstetrics and Gynecology (ACOG)

Mesečne strokovne revije:

1. American Journal of Pathology
2. British Medical Journal
3. Human Reproduction
4. American Jouornal of Obstetrics & Gynecology
5. Journal of the American Medical Association
6. Journal of Allergy and Clinical Immunology
7. Journal of the American Academy of Dermatology
8. Pediatrics
9. Archives of Disease in Childhood
10. American Journal of Pathology
11. European Heart Journal
12. Alcholism: Clinical & Experimental Research
13. The Lancet

Kategorija:   Novice, zdravje
Naslednji prispevek

Vitamin D do petega leta?

13 junija, 2012 0